The Phase I/II study will enrol approximately 368 adults aged 18 years and above.

Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus FamilyNext-generation vaccine leveraging SKYCovione's recombinant protein-based platform and nanoparticle ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Nanosecond PFA 360° Cardiac Catheter for AF ablation to be highlighted in presentations and in a live case transmission “We are gaining significant momentum generating clinical and preclinical ...

Head of Machine Learning, Lucas Camillo, to lead team with Professor Bo Wang, University of Toronto, appointed as Senior Advisor Expansion into global AI hub to accelerate growth of IP portfolio and ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today ...

SAN DIEGO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it has achieved technological proof of concept for ...

MIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced that its nsPFA ...

Dallas-based Colossal says it is one step closer to bringing back the woolly mammoth. Colossal Biosciences announced Tuesday that it had created the Colossal woolly mouse, genetically engineered mice ...

Clinical Data on Benign Thyroid Nodule Ablation to be highlighted in presentation Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary ...

At BD Life Sciences–Biosciences (BDB), we take pride in our history. Since the innovation of our technology in the 1970s where Dr. Leonard Herzenberg of Stanford invented the fluorescence-activated ...